Liposome Formulation of Fullerene-Based Molecular Diagnostic and Therapeutic Agents

Pharmaceutics - Tập 5 Số 4 - Trang 525-541
Zhiguo Zhou1
1Luna Innovations Inc., 521 Bridget Street, Danville 24541, VA, USA

Tóm tắt

Fullerene medicine is a new but rapidly growing research subject. Fullerene has a number of desired structural, physical and chemical properties to be adapted for biological use including antioxidants, anti-aging, anti-inflammation, photodynamic therapy, drug delivery, and magnetic resonance imaging contrast agents. Chemical functionalization of fullerenes has led to several interesting compounds with very promising preclinical efficacy, pharmacokinetic and safety data. However, there is no clinical evaluation or human use except in fullerene-based cosmetic products for human skincare. This article summarizes recent advances in liposome formulation of fullerenes for the use in therapeutics and molecular imaging.

Từ khóa


Tài liệu tham khảo

Kroto, 1985, Buckminsterfullerenes, Nature, 318, 162, 10.1038/318162a0

Jensen, 1996, Biological applications of fullerenes, Bioorg. Med. Chem., 4, 767, 10.1016/0968-0896(96)00081-8

Ross, 1999, Medicinal chemistry with fullerenes and fullerene derivatives, Chem. Commun., 8, 663, 10.1039/a809495k

Nakamura, 2003, Functionalized fullerenes in water. The first 10 years of their chemistry, biology, and nanoscience, Acc. Chem. Res., 36, 807, 10.1021/ar030027y

Bosi, 2003, Fullerene derivatives: An attractive tool for biological applications, Eur. J. Med. Chem., 38, 913, 10.1016/j.ejmech.2003.09.005

Anilkumar, 2011, Fullerenes for applications in biology and medicine, Curr. Med. Chem., 18, 2045, 10.2174/092986711795656225

Bolskar, 2008, Gadofullerene MRI contrast agents, Nanomedicine, 3, 201, 10.2217/17435889.3.2.201

Sinohara, 2000, Endohedral metallofullerenes, Rep. Prog. Phys., 63, 843, 10.1088/0034-4885/63/6/201

Krustic, 1991, Radical reactions of C60, Science, 254, 1183, 10.1126/science.254.5035.1183

Partha, 2009, Biomedical applications of functionalized fullerene-based nanomaterials, Int. J. Nanomed., 4, 261

Tsai, 1997, Polyhydroxylated C60, fullerenol, a novel free-radical trapper, prevented hydrogen peroxide- and cumene hydroperoxide-elicited changes in rat hippocampus in vitro, J. Pharm. Pharmacol., 49, 438, 10.1111/j.2042-7158.1997.tb06821.x

Husebo, 2004, Fullerenols revisited as stable radical anions, J. Am. Chem. Soc., 126, 12055, 10.1021/ja047593o

Huang, 2001, Neuroprotective effect of hexasulfobutylated C660 on rats subjected to focal cerebral ischemia, Free Radic. Biol. Med., 30, 643, 10.1016/S0891-5849(00)00505-0

Dugan, 1997, Carboxyfullerenes as neuroprotective agents, Proc. Natl. Acad. Sci. USA, 94, 9434, 10.1073/pnas.94.17.9434

Brettreich, 1998, A highly water-soluble dendro[60]fullerene, Tetrahedron Lett., 39, 2731, 10.1016/S0040-4039(98)00491-2

Johnston, 2010, The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity, Toxicol. Sci., 114, 162, 10.1093/toxsci/kfp265

Bensasson, 1994, C60 in model biological systems. A visible-UV absorption study of solvent-dependent parameters and solute aggregation, J. Phys. Chem., 98, 3492, 10.1021/j100064a035

Hungerbuhler, 1993, Incorporation of C60 into artificial lipid membranes, J. Am. Chem. Soc., 115, 3386, 10.1021/ja00061a070

Zhou, 2006, Tether directed selective synthesis of fulleropyrrolidine bisadducts, J. Org. Chem., 71, 1545, 10.1021/jo052213i

Zhou, 2005, Tether-directed multiple functionalization of fullerene[60], Curr. Org. Chem., 9, 789, 10.2174/1385272053764971

Zhou, 2005, A new method for the functionalization of [60]fullerene: An unusual 1,3-dipolar cycloaddition pathway leading to a C60 housane derivative, Org. Lett., 7, 5849, 10.1021/ol052393i

Zhou, 2003, Selective syntheses of polyether fullerene multiple adducts, J. Org. Chem., 68, 7612, 10.1021/jo034542l

Zhou, 2010, Liposomal formulation of amphiphilic fullerene antioxidants, Bioconjug. Chem., 21, 1656, 10.1021/bc1001664

Rossi, 2013, Partitioning and solubility of C60 fullerene in lipid membranes, Phys. Scr., 87, 058503, 10.1088/0031-8949/87/05/058503

Zupanc, 2012, Experimental evidence for the interaction of C-60 fullerene with lipid vesicle membranes, Carbon, 50, 1170, 10.1016/j.carbon.2011.10.030

Bouropoulos, 2012, Probing the perturbation of lecithin bilayers by unmodified C60 fullerenes using experimental methods and computational simulations, J. Phys. Chem., 116, 3867

Zhan, 2008, A modular photocurrent generation system based on phospholipid-assembled fullerenes, Langmuir, 24, 13258, 10.1021/la802972p

Gan, 2002, Fullerenes as a tert-butylperoxy radical trap, metal catalyzed reaction of tert-butyl hydroperoxide with fullerenes, and formation of the first fullerene mixed peroxides, J. Am. Chem. Soc., 124, 13384, 10.1021/ja027714p

Birkett, P.R., Avent, A.G., Darwish, A.D., Kroto, H.W., Taylor, R., and Walton, D.R.M. (1995). Formation and characterization of C70Cl10. J. Chem. Soc. Chem. Commun., 683–684.

Scuseria, 1991, The equilibrium structure of C70. An ab initio Hartree-Fock study, Chem. Phys. Lett., 180, 451, 10.1016/0009-2614(91)85148-P

Lens, 2008, Antioxidative capacity of C60 (buckminsterfullerene) and newly synthesized fulleropyrrolidine derivatives encapsulated in liposomes, Biotechnol. Appl. Biochem., 51, 135, 10.1042/BA20080007

Williams, 1996, Incorporaiton of fullerene-C60 and C60 adducts in micellar and vesicular supermolecular assemblies: Introductory flash photolysis and photoredox experiments in micelles, Recl. Trav. Chim. Pays-Bas, 115, 72, 10.1002/recl.19961150114

Dellinger, 2009, Fullerene nanomaterials inhibit phorbol myristate acetate-induced inflammation, Exp. Dermatol., 18, 1079, 10.1111/j.1600-0625.2009.00904.x

Norton, 2012, Epoxyeicosatrienoic acids are involved in the C70 fullerene derivative-induced control of allergic asthma, J. Allergy Clin. Immunol., 130, 761, 10.1016/j.jaci.2012.04.023

Dellinger, 2013, Application of fullerenes in nanomedicine: An update, Nanomedicine, 8, 1191, 10.2217/nnm.13.99

Yamakoshi, 2003, Active oxygen species generated from photoexcited fullerene (C60) as potential medicines: O2−• versus 1O2, J. Am. Chem. Soc., 125, 12803, 10.1021/ja0355574

Ikeda, 2007, An extremely effective DNA photocleavage utilizing functionalized liposomes with a fullerene-enriched lipid bilayer, J. Am. Chem. Soc., 129, 4140, 10.1021/ja070243s

Ikeda, 2005, Efficient photoclevage of DNA utilising water-soluble lipid membrane-incorporated [60]fullerenes prepared using a [60]fullerene exchange method, Org. Biomol. Chem., 3, 2907, 10.1039/b507954c

Ikeda, 2011, Formation and regulation of fullerene-incorporation in liposomes under the phase transition temperature, Org. Biomol. Chem., 9, 2622, 10.1039/c0ob01030h

Du, 2012, The antiviral effect of fullerene-liposome complex against influenza virus (H1N1) in vivo, Sci. Res. Essays, 7, 705

Dellinger, 2013, Functionalization of gadolinium metallofullerenes for detecting atherosclerotic plaque lesions by cardiovascular magnetic resonance, J. Cardiovasc. Magn. Reson., 15, 7, 10.1186/1532-429X-15-7

McFarland, 2008, Hydrochalarones: A novel endohedral metallofullerene platform for enhancing magnetic resonance imaging contrast, J. Med. Chem., 51, 3681, 10.1021/jm800521j

Podrez, 2002, Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36, J. Biol. Chem., 277, 38503, 10.1074/jbc.M203318200

Amirbekian, 2007, Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI, Proc. Natl. Acad. Sci. USA, 104, 961, 10.1073/pnas.0606281104

Nunn, 1997, Can receptors be imaged with MRI agents?, Q. J. Nucl. Med., 41, 155

Zakharian, 2005, A fullerene-paclitaxel chemotherapeutic: Synthesis, characterization, and study of biological activity in tissue culture, J. Am. Chem. Soc., 127, 12508, 10.1021/ja0546525

Shinya, 2011, Fullerene-C60 incorporated in liposome exerts persistent hydroxyl radical-scavenging activity and cytoprotection in UVA/B-irradiated keratinocytes, J. Nanosci. Nanotechnol., 11, 3814, 10.1166/jnn.2011.4172

Kato, 2010, Defensive effects of fullerene-C60/liposome complex against UVA-induced intracellular reactive oxygen species generation and cell death in human skin keratinocytes HaCaT, associated with intracellular uptake and extracellular excretion of fullerene-C60, J. Photochem. Photobiol. B, 98, 144, 10.1016/j.jphotobiol.2009.11.015

Kato, 2010, Fullerene-C60/liposome complex: Defensive effects against UVA-induced damages in skin structure, nucleus and collagen type I/IV fibrils, and the permeability into human skin tissue, J. Photochem. Photobiol. B, 98, 99, 10.1016/j.jphotobiol.2009.11.010

Brettreich, 2000, Globular amphiphiles: Membraneforming hexaadducts of C60, Angew. Chem. Int. Ed., 39, 1845, 10.1002/(SICI)1521-3773(20000515)39:10<1845::AID-ANIE1845>3.0.CO;2-Q

Maierhofer, 2000, Structure and electrostatic interaction properties of monolayers of amphiphilic molecules derived from C60-fullerenes: A film balance, neutron, and infrared reflection study, Langmuir, 16, 8884, 10.1021/la000297e

Partha, 2007, Self-assembly of amphiphilic C60 fullerene derivatives into nanoscale supramolecular structures, J. Nanobiotechnol., 5, 6, 10.1186/1477-3155-5-6

Partha, 2008, Buckysomes: Fullerene-based nanocarriers for hydrophobic molecule delivery, ACS Nano, 2, 1950, 10.1021/nn800422k

Danila, D., Golunski, E., Partha, R., McManus, M., Little, T., and Conyers, J. (2013). Buckysomes: New nanocarriers for anticancer drugs. J. Pharm., 2013.